Growth Metrics

Merck (MRK) EBT Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,234.00
Dec 31, 2025 -1,819.00
Sep 30, 2025 742.00
Jun 30, 2025 -639.00
Mar 31, 2025 1,132.00
Dec 31, 2024 214.00
Sep 30, 2024 -1,272.00
Jun 30, 2024 133.00
Mar 31, 2024 4,993.00
Dec 31, 2023 -4,919.00
Sep 30, 2023 7,046.00
Jun 30, 2023 -6,045.00
Mar 31, 2023 -21.00
Dec 31, 2022 145.00
Sep 30, 2022 -680.00
Jun 30, 2022 18.00
Mar 31, 2022 166.00
Dec 31, 2021 -1,112.00
Sep 30, 2021 2,497.00
Jun 30, 2021 -1,305.00
Mar 31, 2021 5,135.00
Dec 31, 2020 -4,801.00
Sep 30, 2020 -455.00
Jun 30, 2020 -253.00
Mar 31, 2020 6,803.00
Dec 31, 2019 -5,513.00
Sep 30, 2019 -878.00
Jun 30, 2019 -64.00
Mar 31, 2019 468.00
Dec 31, 2018 -101.00
Sep 30, 2018 476.00
Jun 30, 2018 653.00
Mar 31, 2018 -461.00
Dec 31, 2017 1,607.00
Sep 30, 2017 -2,262.00
Jun 30, 2017 333.00
Mar 31, 2017 3,464.00
Dec 31, 2016 -4,081.00
Sep 30, 2016 1,212.00
Jun 30, 2016 -216.00
Mar 31, 2016 945.00
Dec 31, 2015 -1,581.00
Sep 30, 2015 1,555.00
Jun 30, 2015 -641.00
Mar 31, 2015 -9,803.00
Dec 31, 2014 9,857.00
Sep 30, 2014 -318.00
Jun 30, 2014 -308.00
Mar 31, 2014 955.00
Dec 31, 2013 -300.00
Sep 30, 2013 252.00
Jun 30, 2013 -322.00
Mar 31, 2013 316.00
Dec 31, 2012 -794.00
Sep 30, 2012 -246.00
Jun 30, 2012 40.00
Mar 31, 2012 851.00
Dec 31, 2011 -670.00
Sep 30, 2011 580.00
Jun 30, 2011 -117.00
Mar 31, 2011 3,027.00
Dec 31, 2010 -1,981.00
Sep 30, 2010 -646.00
Jun 30, 2010 529.00
Mar 31, 2010 -12,287.00
Dec 31, 2009 11,840.00
Sep 30, 2009 -299.00
Jun 30, 2009 -788.00